You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb2695561 |
|---|---|
| Category | Small Molecules |
| Description | BCR-ABL-IN-9 (Compound B1) is an inhibitor of BCR-ABL that achieves sustained suppression through the formation of stable covalent bonds with the ABL kinase. It effectively inhibits the activity of ABL kinase (IC50 = 1.2 nM) and possesses anticancer activity. |
| Target | Bcr-Abl |
| MW | 388.42 |
| Formula | C22H20N4O3 |
| SMILES | O=C(NC1=CC=CC(=C1)C(=O)C)C2=CC=3C=C4C5=C(C3OC2=N)CCCN5CCC4 |
| Storage | -20°C |
| Research Area | Cardiovascular Research, Signal Transduction |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)